UnitedHealth Group stock gains 0.61% to EUR 361.60 premarket
Published on 11/11/2026 at 08:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points for investors
- UnitedHealth Group's investor calendar lists no upcoming events.
- The company identifies medical-cost management, healthcare regulation and execution as material risks.
- Its investor page lists third-quarter 2026 results among the latest reports.
Premarket move
UnitedHealth Group stock traded at EUR 361.60 on Lang & Schwarz at 08:27 CET on Wednesday, November 11, 2026, 0.61 percent above the Xetra close of Tuesday, November 10, at EUR 359.40.
The move puts the insurer's premarket quote above the previous Xetra session's close ahead of the regular European trading day. Investors continue to weigh the group's earnings outlook against execution risks.
Investor calendar stays quiet
UnitedHealth Group's investor relations page lists no upcoming events and names third-quarter 2026 results among its latest reports. The company also flags medical-cost management, healthcare regulation, government-program exposure and execution of strategic initiatives as material business risks.
The broader US market context remains relevant for UnitedHealth Group stock as investors assess the S&P 500.
